EUVIMEDEUVIMED entdecken
Systematische Übersicht

Blood and brain exosomes as biomarkers for schizophrenia diagnosis: a systematic review

Ali Reza Shafiee-Kandjani, Leila Hosseini, Mohammad Karimipour, Parinaz kalejahi, Fatemehsadat Seyedaghamiri, Roshanak Sambrani

Medical Journal of Tabriz University of Medical Sciences · 16.03.2026 · 47 (6) · 602-617

DOI: 10.34172/mj.026.35137 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Journal of Tabriz University of Medical Sciences, online erschienen am 11.01.2026. Verfasst von Ali Reza Shafiee-Kandjani und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Schizophrenia, as a chronic and debilitating mental illness, often results in a decrease in the quality of life of patients. This systematic review aimed to investigate blood and brain exosomes as biomarkers for the diagnosis of schizophrenia.

Methods

In this systematic review, articles on the role of exosomes and their molecular content in patients with schizophrenia were identified by searching PubMed, Scopus, Embase, and Web of Science databases up to July 2025.

Results

A total of 215 articles were reviewed, and 19 studies were selected for inclusion. Our findings revealed that the molecular content of exosomes, including proteins, metabolites, and circRNA, differs significantly between individuals with schizophrenia and healthy controls. These biomarkers are associated with key pathophysiological signaling pathways, including neurotransmission, mitochondrial processes, neuroinflammation, and metabolism.

Conclusion

The use of exosomes as biomarkers can enhance diagnostic accuracy and provide better insight into the molecular mechanisms involved in the development and manifestation of schizophrenia. Practical Implications. Exosomes can be used as biomarkers for the diagnosis of schizophrenia. They have the potential to serve as non-invasive tools for the diagnosis of schizophrenia, assessment of response to treatment, and development of targeted therapies for this mental disease. The findings of the present study provide a new perspective for the personalization of therapy for individuals with schizophrenia and the early treatment of these patients.

Zitieren

APA

Shafiee-Kandjani, A. R., Hosseini, L., Karimipour, M., kalejahi, P., Seyedaghamiri, F., & Sambrani, R. (2026). Blood and brain exosomes as biomarkers for schizophrenia diagnosis: a systematic review. Medical Journal of Tabriz University of Medical Sciences, 47(6), 602-617. https://doi.org/10.34172/mj.026.35137

Vancouver

Shafiee-Kandjani AR, Hosseini L, Karimipour M, kalejahi P, Seyedaghamiri F, Sambrani R. Blood and brain exosomes as biomarkers for schizophrenia diagnosis: a systematic review. Medical Journal of Tabriz University of Medical Sciences. 2026;47(6):602-617. doi:10.34172/mj.026.35137

BibTeX
@article{ShafieeKandjani2026,
  author = {Shafiee-Kandjani, Ali Reza and Hosseini, Leila and Karimipour, Mohammad and kalejahi, Parinaz and Seyedaghamiri, Fatemehsadat and Sambrani, Roshanak},
  title = {Blood and brain exosomes as biomarkers for schizophrenia diagnosis: a systematic review},
  journal = {Medical Journal of Tabriz University of Medical Sciences},
  year = {2026},
  volume = {47},
  number = {6},
  pages = {602--617},
  doi = {10.34172/mj.026.35137}
}
Kostenlos starten →